Avadel Pharmaceuticals (AVDL) Current Leases: 2010-2022
Historic Current Leases for Avadel Pharmaceuticals (AVDL) over the last 4 years, with Sep 2022 value amounting to $1.0 million.
- Avadel Pharmaceuticals' Current Leases rose 100.60% to $1.0 million in Q3 2022 from the same period last year, while for Sep 2022 it was $1.0 million, marking a year-over-year increase of 100.60%. This contributed to the annual value of $900,000 for FY2021, which is 89.87% up from last year.
- Per Avadel Pharmaceuticals' latest filing, its Current Leases stood at $1.0 million for Q3 2022, which was up 8.48% from $932,000 recorded in Q2 2022.
- Avadel Pharmaceuticals' Current Leases' 5-year high stood at $1.6 million during Q3 2019, with a 5-year trough of $474,000 in Q4 2020.
- Over the past 3 years, Avadel Pharmaceuticals' median Current Leases value was $563,000 (recorded in 2020), while the average stood at $673,000.
- As far as peak fluctuations go, Avadel Pharmaceuticals' Current Leases slumped by 67.42% in 2020, and later soared by 100.60% in 2022.
- Quarterly analysis of 4 years shows Avadel Pharmaceuticals' Current Leases stood at $645,000 in 2019, then declined by 26.51% to $474,000 in 2020, then skyrocketed by 89.87% to $900,000 in 2021, then spiked by 100.60% to $1.0 million in 2022.
- Its Current Leases stands at $1.0 million for Q3 2022, versus $932,000 for Q2 2022 and $917,000 for Q1 2022.